Holen Sie sich die Stockscreener-App
2.59
1.89%
-0.05
Finanzdaten der X 4 Pharmaceuticals Inc-Aktie (XFOR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
4.00%
2.40
|
2.50 | 2.20 | 1.566 | 1.744 |
| Cost Of Revenue |
170.40%
1.617
|
0.598 | 0.364 | 0.351 | 0.326 |
| Research and Development |
2.40%
15.08
|
15.45 | 18.52 | - | - |
| Operating Income/Loss |
19.28%
-16.39
|
-20.31 | -23.70 | -27.51 | -26.23 |
| Nonoperating Income/Loss |
263.08%
0.236
|
0.065 | -0.226 | -2.336 | 0.528 |
| Income/Loss From Continuing Operations Before Tax |
20.19%
-16.16
|
-20.24 | -23.93 | -29.84 | -25.70 |
| Income Tax Expense/Benefit |
0.002
|
- | - | -0.03 | 0.037 |
| Net Income/Loss |
20.18%
-16.16
|
-20.24 | -23.93 | -29.82 | -25.74 |
| Basic Average Shares |
0.04%
126.34
|
126.29 | - | 43.27 | 7.413 |
| Diluted Average Shares |
0.04%
126.34
|
126.29 | - | 43.27 | 7.413 |
| Basic Earnings Per Share |
18.75%
-0.13
|
-0.16 | - | -0.69 | -3.47 |
| Diluted Earnings Per Share |
18.75%
-0.13
|
-0.16 | - | -0.69 | -3.47 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):